Clinical Trials Browser

Phase 1/2 × Opdualag × 30 days × Clear all

NCT07281924 2026-03-02

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

Phase 1/2 Recruiting

Melanoma